Supports multidisciplinary research projects aimed at discovering and validating biomarkers for alcohol-related cardiovascular and cerebrovascular diseases. Encourages use of AI-enabled analytics, multimodal datasets, longitudinal cohorts, and precision diagnostics to improve early detection, risk prediction, disease phenotyping, and mechanistic understanding of alcohol-related cardiovascular injury and progression. Funding is available through NIH SBIR/STTR for small businesses developing innovative biomarker and diagnostic platforms.
Eligible applicants are U.S. small business concerns organized for profit with a U.S. place of business, having 500 or fewer employees, and majority owned by U.S. citizens or permanent residents.
